August 18, 2007
PSA Velocity Over 2 NG/ML Year Pre Diagnosis Independently Predicts Prostate Cancer Mortality In Men Treated With Radical Prostatectomy/Radiotherapy
UroToday.com - In the past, prostate cancer risk stratification before definitive treatment had been largely based on preoperative serum PSA, Gleason score, clinical stage, and the percent of positive biopsies on biopsy. Recently, PSA velocity before diagnosis has been increasingly implicated in prostate cancer prognosis. [click link for full article]
More: continued here





















Leave a comment